HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.

TitleHSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.
Publication TypeJournal Article
Year of Publication2012
AuthorsMendillo ML, Santagata S, Koeva M, Bell GW, Hu R, Tamimi RM, Fraenkel E, Ince TA, Whitesell L, Lindquist S
JournalCell
Volume150
Issue3
Pagination549-62
Date Published2012 Aug 03
ISSN1097-4172
KeywordsBreast Neoplasms, Cell Line, Tumor, Cells, Cultured, DNA-Binding Proteins, Female, Gene Expression Regulation, Neoplastic, Gene Regulatory Networks, Genome, Human, Heat Shock Transcription Factors, Humans, Neoplasms, Transcription Factors
Abstract

Heat-Shock Factor 1 (HSF1), master regulator of the heat-shock response, facilitates malignant transformation, cancer cell survival, and proliferation in model systems. The common assumption is that these effects are mediated through regulation of heat-shock protein (HSP) expression. However, the transcriptional network that HSF1 coordinates directly in malignancy and its relationship to the heat-shock response have never been defined. By comparing cells with high and low malignant potential alongside their nontransformed counterparts, we identify an HSF1-regulated transcriptional program specific to highly malignant cells and distinct from heat shock. Cancer-specific genes in this program support oncogenic processes: cell-cycle regulation, signaling, metabolism, adhesion and translation. HSP genes are integral to this program, however, many are uniquely regulated in malignancy. This HSF1 cancer program is active in breast, colon and lung tumors isolated directly from human patients and is strongly associated with metastasis and death. Thus, HSF1 rewires the transcriptome in tumorigenesis, with prognostic and therapeutic implications.

DOI10.1016/j.cell.2012.06.031
Alternate JournalCell
PubMed ID22863008
Grant ListK08NS064168 / NS / NINDS NIH HHS / United States
CA087969 / CA / NCI NIH HHS / United States
R01-CA146445-01 / CA / NCI NIH HHS / United States
CA089393 / CA / NCI NIH HHS / United States
Related Faculty: 
Tan Ince, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700